Conducting Early Phase Oncology Studies, Successfully Moving Through to Proof of Concept, New Webinar Hosted by Xtalks
/EINPresswire.com/ -- TORONTO, ON--(Marketwired - October 23, 2017) - This one-hour webinar will focus on considerations for drug developers, and in particular, small, young biotech, when selecting a Clinical Research Organisation (CRO) to take their molecule through to proof of concept and beyond.
Key topics include:
- Strategic considerations for the molecule, a brief review the dynamic research landscape of oncology drug development, patient recruitment and product development aspects. What is on the horizon in oncology drug development
- Clinical development strategy and tactics
- Clinical design and consideration
- Early V Late Phase
- Regulatory considerations
- Clinical aspects -- cure or control
- Patient centricity -- practical considerations
- Trial design -- early phase 3+3, Rolling 6 and other designs. Biomarkers
- Protocol development -- clear unambiguous protocols, sense checking with KOL's and subject matter experts. The importance of understanding how to 'operationalize' the protocol with thorough feasibility
- Proof of concept -- how do you confirm for MAA
To learn more information about this complimentary event visit: Conducting Early Phase Oncology Studies, Successfully Moving Through to Proof of Concept.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx
Image Available: http://www.marketwire.com/library/MwGo/2017/10/23/11G146821/Images/SIMBEC_ORION_COLOUR-5ce426eeef8b9483ab91e999152139fd.JPG
Contact:
Nima Rajan
Tel: +1 (416) 977-6555 ext 352
Email: nrajan@xtalks.com
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.